Match Document Document Title
US20100330183 SOLID DISPERSING VACCINE COMPOSITION FOR ORAL DELIVERY  
The invention disclosed herein relate to an oral vaccine in which the vaccine composition and adjuvant(s) are carried on a solid fast-dispersing dosage form. The vaccines are targeted toward...
US20110212157 DERMAL DELIVERY  
The present invention describes systems and methods for treating disorders and/or conditions associated with the dermal level of the skin. Such disorders include acne, hyperhidrosis, bromhidrosis,...
US20110135730 Oral Formulations of Glycyl-2-Methylprolyl-Glutamate  
Oral formulations of G-2MePE including microemulsions, coarse emulsions, liquid crystals, tablets and encapsulated forms of G-2MePE have improved bioavailability than conventional aqueous...
US20110250274 ESTRIOL FORMULATIONS  
Disclosed herein are oral dosage forms and methods of their use, in particular oral dosage systems for the delivery of estriol compounds. Embodiments described herein relate to rapidly...
US20110076326 MODIFIED PROTEIN EXCIPIENT FOR DELAYED-RELEASE TABLET  
The present invention relates to delayed release oral formulations comprising active ingredients and modified proteins used as excipients. The proteins have chemical modifications such as...
US20110020450 TITRATABLE DOSAGE TRANSDERMAL DELIVERY SYSTEM  
The present invention relates to a titratable dosage transdermal delivery system for systemic delivery of a therapeutic agent or drug. The system comprises a plurality of patch units that are...
US20110117193 ANTIRETROVIRAL DRUG FORMULATIONS FOR TREATMENT OF CHILDREN EXPOSED TO HIV/AIDS  
The present disclosure provides fast disintegrating formulations for the treatment of human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) in patients such as...
US20140065210 PROTEIN STABILIZED PROBIOTICS AND PERSONAL CARE PRODUCTS  
The present invention relates to a personal care product comprising a protein matrix wherein said protein matrix comprises at least one protein, at least one probiotic and a carrier fluid. The...
US20140086989 Protein Matrix Vaccine Compositions Including Polycations  
The present invention relates to immunogenic compositions containing one or more antigens of interest, one or more carrier proteins, and one or more polycations, wherein the antigen of interest is...
US20110151005 METHODS AND MEANS FOR SOFT TISSUE ENGINEERING  
Cellfree adipose tissue extracts, implants including the same and methods for the preparation thereof. The extracts and implants are capable of inducing adipogenesis and angiogenesis and are,...
US20110196502 Methods of Using Water-Soluble Inorganic Compounds for Implants  
A method for controlling generation of biologically desirable voids in a composition placed in proximity to bone or other tissue in a patient by selecting at least one water-soluble inorganic...
US20110027364 BIOACTIVE AND RESORBABLE SOYBEAN-BASED BIOMATERIALS  
A method of producing a soybean-based biomaterial which is suitable for use in a biomedical product, the method comprising: defatting soy flour; either prior to or at the same time as, performing...
US20110206759 CCR7 LIGAND DELIVERY AND CO-DELIVERY IN IMMUNOTHERAPY  
Chemokines may be administered to a patient for immunotolerization. Chemokines include CCL19 and CCL21. Materials and methods for accomplishing tolerization and described.
US20140099369 TAMPER-RESISTANT ORAL OPIOID AGONIST FORMULATIONS  
Disclosed is an oral dosage form comprising: (i) an opioid agonist in releasable form and (ii) a sequestered opioid antagonist which is not released when the dosage form is administered orally intact.
US20130251789 TAMPER-RESISTANT ORAL OPIOID AGONIST FORMULATIONS  
Disclosed is an oral dosage form comprising: (i) an opioid agonist in releasable form and (ii) a sequestered opioid antagonist which is not released when the dosage form is administered orally intact.
US20120288565 TAMPER-RESISTANT ORAL OPIOID AGONIST FORMULATIONS  
Disclosed is an oral dosage form comprising: (i) an opioid agonist in releasable form and (ii) a sequestered opioid antagonist which is not released when the dosage form is administered orally intact.
US20110097404 TAMPER-RESISTANT ORAL OPIOID AGONIST FORMULATIONS  
Disclosed is an oral dosage form comprising (i) an opioid agonist in releasable form and (ii) a sequestered opioid antagonist which is not released when the dosage form is administered orally intact.
US20120003315 Flowable Carrier Matrix  
A carrier matrix may be delivered to a target position within a patient in a minimally invasive manner by first cutting a collagen sponge sheet into a plurality of relatively small pieces. These...
US20110092953 Flowable Carrier Matrix  
A carrier matrix may be delivered to a target position within a patient in a minimally invasive manner by first cutting a collagen sponge sheet into a plurality of relatively small pieces. These...
US20110256223 GASTRIC RETAINED GABAPENTIN DOSAGE FORM  
A method of treatment for epilepsy and other disease states is described, which comprises the delivery of gabapentin in a gastric retained dosage form.
US20120071865 FLOWABLE HYDROGELS FOR CONTROL OF CELL IN-MIGRATION  
Materials and methods of treating an eye with a hydrogel formed on the eye. Embodiments are provided that include post-keratectomy bandages.
US20120010599 INORGANICALLY SURFACE-MODIFIED POLYMERS AND METHODS FOR MAKING AND USING THEM  
In alternative embodiments, the invention provides articles of manufacture comprising biocompatible nanostructures comprising PolyEther EtherKetone (PEEK) surface-modified (surface-nanopatterned)...
US20110129801 COMPOSITIONS AND METHODS TO PREVENT AND TREAT DRY SOCKET POST-OPERATIVELY AFTER TOOTH EXTRACTION SURGERY  
The invention describes and claims compositions and methods for their use in the prevention and treatment of alveolar osteitis (dry socket) after tooth extraction surgery.
US20110182957 CELLULOSICS FOR TISSUE REPLACEMENT  
This invention relates to biomaterial compositions, methods and kits for producing hydrogels with tunable physico-chemical properties. Specifically, the invention relates to producing cellulosic...
US20140178473 SOLID DOSAGE FORM  
There is provided a solid dosage form adapted for the release of a biologically active material in the oral cavity wherein the dosage form includes at least one biologically active material, and...
US20100297224 NSAID Dose Unit Formulations with H2-Receptor Antagonists and Methods of Use  
The present invention generally relates to pharmaceutical unit dosage forms of NSAIDs and H2-receptor antagonists, in which the H2-receptor antagonist is formulated so as to be released in a...
US20100322994 PARTICULATE CARTILAGE SYSTEM  
The present invention is directed to compositions having at least one neocartilage particle, juvenile cartilage particle or a combination thereof and a matrix, and methods and devices that include...
US20130224292 ACAMPROSATE FORMULATIONS, METHODS OF USING THE SAME, AND COMBINATIONS COMPRISING THE SAME  
Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other...
US20100310658 Electroprocessed Fibrin-Based Matrices and Tissues  
The invention is directed to formation and use of electroprocessed fibrin as an extracellular matrix and, together with cells, its use in forming engineered tissue. The engineered tissue can...
US20130122096 COMPOSITIONS FOR DRUG DELIVERY AND METHODS OF MANUFACTURING AND USING SAME  
Polymeric implants containing microparticles and nanoparticles, delivery of microparticles and nanoparticles from a polymeric implant is provided.
US20110064810 TISSUE ENGINEERING METHOD FOR ORGAN RECONSTRUCTION USING INJECTABLE MATRIX  
The various embodiments herein relate to an injectable matrix used for regeneration, reconstruction, repair or replacement of organ or tissue. The injectable matrix consists of a synthetic and...
US20100316720 Use of an extract from snow algae in cosmetic or dermatological formulations  
The present invention relates to the use of an extract from snow algae, especially an extract from Chlamydocapsa sp (snow algae) in cosmetic and/or pharmaceutical products. More particularly, the...
US20110305760 TISSUE REGENERATION SYSTEM  
A system for growing tissue based upon layers of an inorganic extracellular matrix, wherein each layer of the inorganic matrix is designed to dissolve at a separate rate and result in sequential...
US20120114754 RAPIDLY DISINTEGRATING SOLID ORAL DOSAGE FORM  
Disclosed is a rapidly disintegrating solid oral dosage form of a poorly soluble active ingredient and at least one pharmaceutically acceptable water-soluble or water-dispersible excipient,...
US20110002996 ACELLULAR TISSUE MATRICES MADE FROM ALPHA-1,3-GALACTOSE-DEFICIENT TISSUE  
The invention provides acellular tissue matrices made from collagen-containing tissues of animals genetically modified so as to be deficient in the galactose 1,3-galactose epitope and methods of...
US20110097406 METHODS AND COMPOSITIONS FOR RETAINING ECM MATERIALS IN HYDROGELS  
The present invention provides cell-laden and/or extracellular matrix material laden hydrogels for use in tissue engineering and methods for producing such hydrogels. In some particular...
US20130136796 Acellular Bioabsorbable Tissue Regeneration Matrices  
The present invention provides methods and compositions useful in the regeneration of damaged, lost and/or degenerated tissue in humans and animals. In certain embodiments, the present invention...
US20100316717 INJECTABLE HYDROGEL MICROSPHERES FROM AQUEOUS TWO-PHASE SYSTEM  
Injectable hydrogel microspheres are prepared by forming an emulsion where hydrogel precursors are in a disperse aqueous phase and polymerizing the hydrogel precursors. In a preferred case, the...
US20100330176 Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity  
The invention relates to the use of ambroxol and the pharmacologically acceptable salts thereof for preparing a pharmaceutical composition for the treatment of painful conditions in the oral and...
US20110064809 SCAFFOLDS  
The invention relates to methods of preparing tissue implants for use in the augmentation, repair and regeneration of tissues.
US20120219628 FAST DISSOLVING SOLID DOSAGE FORM  
There is provided a fast dissolving solid dosage form adapted for the release of a biologically active material in the oral cavity wherein the dosage form comprises at least one biologically...
US20110229574 POLYSACCHARIDE AND PROTEIN-POLYSACCHARIDE CROSS-LINKED HYDROGELS FOR SOFT TISSUE AUGMENTATION  
Disclosed herein are cohesive soft tissue fillers, for example, dermal and subdermal fillers, based on hyaluronic acids and optionally including proteins. In one aspect, hyaluronic acid-based...
US20140234418 METHOD FOR TREATING INTESTINAL FIBROSIS  
A method for treating intestinal fibrosis in a subject, comprising enterally administering a steroid to the subject. The steroid may be in a multiple minibead formulation.
US20100330181 Biphasic implant device providing gradient  
Tissue implants prepared for the repair of tissues, especially avascular tissues such as cartilage. One embodiment presents an electric potential capable of receiving and accumulating desirable...
US20110082482 Materials and Methods for Nerve Repair  
The subject invention pertains to compositions and methods for promoting repair of damaged nerve tissue. The compositions and methods of the subject invention can be employed to restore the...
US20110117018 COMPOSITIONS AND METHODS FOR TREATING BONE  
The present invention relates to compositions, methods and kits for the treatment of bone particularly impaired or damaged bone.
US20150202304 ENCAPSULATION OF IMMISCIBLE PHASES IN SILK FIBROIN BIOMATERIALS  
Embodiments of various aspects described herein relates to compositions and methods for encapsulation and/or stabilization of oil, lipid, hydrophobic and/or lipophilic compounds in a silk-based...
US20140356432 MODALITIES FOR THE TREATMENT OF DEGENERATIVE DISEASES OF THE RETINA  
This invention relates to methods for improved cell-based therapies for retinal degeneration and for differentiating human embryonic stem cells and human embryo-derived into retinal pigment...
US20110091550 Methods for Promoting the Revascularization and Reenervation of CNS Lesions  
The present invention provides methods of promoting the revascularization and/or reenervation of central nervous system lesions using an in-situ crosslinkable hydrogel.
US20110142939 Use of a Combination of an Opioid Agonist and an Opioid Antagonist for the Treatment of Crohn's Disease and the Symptoms Associated with Crohn's Disease  
The present invention is concerned with the use of combinations of opioid agonists and antagonists for treating Crohn's disease.